Connect with us

Canada Pledges Abortion Pill Access If US Bans It 

Holland McKinnie
Like Freedom Press? Get news that you don't want to miss delivered directly to your inbox

In response to recent legal battles surrounding the controversial abortion pill, mifepristone, the Canadian government has indicated that it would assist American women seeking access to the drug if it becomes banned in the United States. Families Minister Karina Gould expressed concern over the potential criminalization of women trying to access abortions, asserting that Canada must be cautious to avoid putting American women and healthcare providers in danger.

The future of mifepristone in the U.S. remains uncertain as the Supreme Court ruled last Friday to pause an order to restrict access following a Texas Judge’s ruling that the drug should not be allowed. This decision was made because the FDA had expedited the process to approve the pill for elective chemical abortions on a wide scale.

Canada’s stance on abortion differs significantly from the U.S., with more lenient regulations and availability at later stages of pregnancy. Prior to the Supreme Court overturning Roe v. Wade, Gould stated that Americans would be able to get an abortion in Canada. She reinforced this position, saying, “If they, people, come here and need access, certainly, you know, that’s a service that would be provided.”

Former Vice President Mike Pence has opposed mifepristone, arguing that the medication should be removed from the market to protect the unborn. In addition, he expressed deep concerns about the FDA’s approval process, stating that the U.S. has a responsibility to safeguard both the unborn and women’s health.

As the abortion pill’s availability in the U.S. hangs in the balance, the Canadian government is taking proactive steps to address potential challenges. Although Gould acknowledged that they are “not there yet” regarding an ample supply of mifepristone, the federal government is actively considering and engaging in conversations about the issue.

The debate over mifepristone has intensified since the end of Roe v. Wade, which had previously granted women a constitutional right to abortion access under the 14th Amendment’s right to privacy. The decision has led to more than a dozen states restricting abortion access while other states are pursuing legislation to limit the procedure further. In contrast, some Democrat-led states have enacted laws to protect abortion access.

Gould’s reassurance to provide access to abortion services and medication for American women in need reflects Canada’s commitment to reproductive healthcare. While the legality of mifepristone in the U.S. remains contested, Canada is preparing to offer support and access to the drug if necessary, demonstrating a contrasting approach to reproductive rights.